Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study

ClinicalTrials.gov ID: NCT01077401

Public ClinicalTrials.gov record NCT01077401. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 5:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT01077401
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Johns Hopkins University
Other
Enrollment
152 participants

Conditions and interventions

Interventions

  • ranibizumab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2010
Primary completion
Feb 29, 2012
Completion
Feb 28, 2013
Last update posted
Apr 27, 2017

2010 – 2013

United States locations

U.S. sites
13
U.S. states
9
U.S. cities
13
Facility City State ZIP Site status
Retina Vitreous Associates Beverly Hills California 90211
University of California San Diego La Jolla California 92037
Doheny Eye Institute Los Angeles California 90033
East Bay Retina Institute Oakland California 94609
Retina Macula Institute Torrance California 90503
Retina Group of Florida Fort Lauderdale Florida 33334
Retina Institute of Hawaii Honolulu Hawaii 96815
Illinois Retina Associates Joliet Illinois 60435
University of Kansas Prairie Village Kansas 66208
Johns Hopkins University Wilmer Eye Institute Baltimore Maryland 21287
Eye Care Specialists Kingston Pennsylvania 18704
Black Hills Eye Institute Rapid City South Dakota 57701
Texas Retina Associates Arlington Texas 76012

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01077401, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 27, 2017 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01077401 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →